Ascensión
López Díaz de Cerio
Profesional Investigadora
Ascensión López Díaz de Cerio-rekin lankidetzan egindako argitalpenak (13)
2024
-
Dendritic Cells in Cancer Immunology and Immunotherapy
Cancers, Vol. 16, Núm. 5
2019
-
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Nature Medicine, Vol. 25, Núm. 3, pp. 470-476
2018
-
A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis
Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1
-
Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients
Annals of Oncology, Vol. 29, Núm. 5, pp. 1312-1319
2017
-
Targeting NK-cell checkpoints for cancer immunotherapy
Current Opinion in Immunology, Vol. 45, pp. 73-81
2008
-
IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis
European Journal of Immunology, Vol. 38, Núm. 2, pp. 576-586
2007
-
Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions
Journal of Investigative Dermatology, Vol. 127, Núm. 7, pp. 1673-1680
2006
-
Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma
Journal of the National Cancer Institute, Vol. 98, Núm. 18, pp. 1292-1301
2004
-
Inmunoterapia activa en el tratamiento de neoplasias hematológicas
Anales del sistema sanitario de Navarra, Vol. 27, Núm. 1, pp. 45-62
-
Past, present and future of anti-idiotype vaccination
Revista de medicina de la Universidad de Navarra, Vol. 48, Núm. 3, pp. 14-23
2003
-
CD4+/CD25+ Regulatory Cells Inhibit Activation of Tumor-Primed CD4+ T Cells with IFN-γ-Dependent Antiangiogenic Activity, as well as Long-Lasting Tumor Immunity Elicited by Peptide Vaccination
Journal of Immunology, Vol. 171, Núm. 11, pp. 5931-5939
-
Potentiation of Therapeutic Immune Responses against Malignancies with Monoclonal Antibodies
Clinical Cancer Research, Vol. 9, Núm. 15, pp. 5454-5464
2001
-
Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity
European Journal of Immunology, Vol. 31, Núm. 6, pp. 1780-1789